Omixon, INC.:1264669 [20-000026]
Ended Purchase Order Awarded Last action
- Contract number
- 75N90020P00074
- Awardee
-
Omixon, Inc. UEI DW2PPM9LS8W4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $201,985
Award facts
- Opportunity
-
- Omixon / Various Holotype Next Generation Sequencing (NGS) typing kits. Pre-Solicitation · 20000026 · Posted Oct 22, 2019
- Contract value 100% obligated
- $201,985.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a firm fixed-price purchase order to Omixon, Inc. for $201,985.00 on November 29, 2019, with completion by November 30, 2020. Work is performed in Cambridge, Massachusetts. The order procures HLA genotyping kits, complementary reagents, and software solutions for HLA analysis supporting transplantation research and immunological studies. The pre-solicitation opportunity was posted October 22, 2019 with a November 6, 2019 due date.
Quick answers
Who was awarded contract 75N90020P00074?
75N90020P00074 was awarded to Omixon, Inc. by NIH Clinical Center (National Institutes of Health) on November 29, 2019.
How much is contract 75N90020P00074 worth?
The government has obligated $201,985 on 75N90020P00074.
Was contract 75N90020P00074 competed?
The extent of competition for 75N90020P00074 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award